Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
47.59
0.94 (2.02%)
BSENSE

Oct 09

BSE+NSE Vol: 4.19 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "47.59",
    "chg": 0.94,
    "chgp": "2.02%",
    "dir": 1,
    "prev_price": "46.65",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "4.19 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 7,
    "sid": "1002696",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Sep-2026",
      "details": "Pursuant to SEBI (PIT) Regulations 2015 as amended and as per Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for dealing in the securities of the Company shall remain closed for designated persons and their immediate relatives from Thursday 01st October 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th September 2026 would be considered by the Board.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "23-Sep-2026",
      "details": "With refrence to the 49th Annual General Meeting of the Company held on Tuesday 22nd September 2026 at 04:00 P.M. IST through Video Conference/ Other Audio Visual Means please find attached Scrutinizers Report dated 23rd September 2026 of remote e-voting along with Voting results.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "22-Sep-2026",
      "details": "The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday 22nd September 2026 at 04:00 P.M. IST through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) is attached herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

24-Sep-2026 | Source : BSE

Pursuant to SEBI (PIT) Regulations 2015 as amended and as per Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for dealing in the securities of the Company shall remain closed for designated persons and their immediate relatives from Thursday 01st October 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th September 2026 would be considered by the Board.

Shareholder Meeting / Postal Ballot-Scrutinizers Report

23-Sep-2026 | Source : BSE

With refrence to the 49th Annual General Meeting of the Company held on Tuesday 22nd September 2026 at 04:00 P.M. IST through Video Conference/ Other Audio Visual Means please find attached Scrutinizers Report dated 23rd September 2026 of remote e-voting along with Voting results.

Shareholder Meeting / Postal Ballot-Outcome of AGM

22-Sep-2026 | Source : BSE

The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday 22nd September 2026 at 04:00 P.M. IST through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) is attached herewith.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23